AMA Clinical Examples in Radiology - 2009 Issue 4 (Fall)
Nuclear Medicine Whole Body Thyroid Carcinoma Metastases Study
Nuclear Medicine Whole Body Thyroid Carcinoma Metastases Study There are two different types of uptake studies: uptake within the thyroid bed and uptake outside the thyroid bed. Iodine uptakes performed within the thyroid bed are appropriately reported with code 78000 (Thyroid uptake; single determination) or 78001 (Thyroid uptake; multiple determinations). When radioiodine uptake measurement is performed in areas of thyroid metastatic disease outside of the thyroid region identified on scan, the add-on code 78020 should be reported in conjunction with code 78018 . Uptakes for metastases are typically determined using radioactive iodine (I-131 sodium iodide or I-123 sodium iodide). Although...
Subscribe or sign in to view the full article.
Article Overview
This premium coding article covers nuclear medicine whole-body thyroid carcinoma metastases studies and the related reporting considerations for associated radiopharmaceutical supply and therapy. It is aimed at coders and billing professionals who work with oncology imaging, thyroid cancer follow-up, and nuclear medicine services. The article discusses general study types, scan timing, and the difference between diagnostic and therapeutic radiopharmaceutical reporting in the context of thyroid cancer imaging.
Why This Topic Matters
Thyroid cancer imaging can involve multiple study components and linked radiopharmaceutical services, so correct code selection affects claim accuracy and compliance. This article helps readers understand the scope of the study, the related code sets, and the general documentation context used in nuclear medicine thyroid metastases cases.
Article Sections
-
Overview of thyroid uptake studies
Introduces the general distinction between uptake measurements performed in different anatomic areas and frames the broader nuclear medicine context for thyroid cancer imaging.
-
Whole body scan, therapy, and follow-up imaging scenario
Summarizes a sample thyroid cancer imaging and treatment sequence involving pretreatment scanning, radiopharmaceutical therapy, and post-therapy follow-up imaging.
-
Examination, findings, and impression
Presents the clinical exam context, imaging findings, and final impression for a whole body I-131 scan case example.
-
Discussion
Provides background on whole body iodine scanning in differentiated thyroid carcinoma and describes the general reporting context for associated imaging and radiopharmaceutical supply services.
-
Reference
Lists the source reference material cited by the article.
What You Will Learn
- How this article frames whole body thyroid carcinoma metastases studies in nuclear medicine
- Which broad code sets are associated with the imaging, therapy, and radiopharmaceutical supply components
- The general clinical and documentation context for thyroid cancer follow-up imaging
- How the article distinguishes diagnostic and therapeutic radiopharmaceutical reporting at a high level
Who Should Read This
- Medical coders
- Billing staff
- Nuclear medicine professionals
- Radiology coding specialists
- Oncology revenue cycle staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com
